glp 1 for teenagers Use of injectable GLP-1 weight-loss drugs skyrockets among teens GLP-1 prescribing among teens with

In the ACHIEVE-1 study, a 36 mg dose resulted in a reduction in HbA1c of 1.31.6% from a baseline of 8.0%, and an average weight loss of 7.9% (approximately 16.0 lbs) over 40 weeks

And it's also easy to forget that though a lot of people are using this for weight loss, most are using it for diabetes and may have other comorbid conditions that make them more susceptible to some of these rare side effects, Dr

Ozempic offers a promising option for some patients, particularly those struggling with insulin resistance and weight management

Access this article Similar content being viewed by others References GBD 2021 Diabetes Collaborators

Dakin, C

received clinical commissioned/joint research grant from asken, scholarship grant from Sumitomo Pharma, Mitsubishi Tanabe Pharma and Nippon Boehringer Ingelheim, and honoraria for lectures from Novo Nordisk Pharma, Sumitomo Pharma, Eli Lilly Japan and Mitsubishi Tanabe Pharma